Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension-Reference-Cited by-同舟云学术

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension

Published:2014-08-22 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Li Edmond CK¹,Heran Balraj S²,Wright James M²

Affiliation:

1. University of Saskatchewan; Anesthesiology, Perioperative Medicine and Pain Management; Royal University Hospital 103 Hospital Dr. Saskatoon SK Canada S7N 0W8

2. University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3

Publisher

Wiley

Subject

Pharmacology (medical)

Reference40 articles.

1. Valsartan: long-term efficacy and tolerability compared to lisinopril in elderly patients with essential hypertension;Bremner;Clinical & Experimental Hypertension,1997

2. Angiotensin-receptor blockade versus converting-enzyme inhibition in Type 2 diabetes and nephropathy;Barnett;New England Journal of Medicine,2004

3. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation;Fogari;American Journal of Hypertension,2008

4. Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation;Fogari;Journal of Cardiovascular Pharmacology and Therapeutics,2011

5. Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy;Fogari;Expert Opinion on Pharmacotherapy,2012

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population‐based cross‐sectional study;The Journal of Clinical Hypertension;2024-07-16

2. The Evolving Role of Chlorthalidone and Hydrochlorothiazide as First-Line Treatments for Hypertensive Patients;Cureus;2024-07-04

3. Marine Microalgal Products with Activities against Age-Related Cardiovascular Diseases;Marine Drugs;2024-05-17

4. Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients;Infectious Disease Reports;2024-05-16

5. Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process;Antioxidants;2024-05-09